Development of Supplements of Calcium Microencapsulated with Brewer's Spent Yeast Mannoproteins-Study of Gastrointestinal and Colonic Bioaccessibility
- PMID: 40807569
- PMCID: PMC12346725
- DOI: 10.3390/foods14152632
Development of Supplements of Calcium Microencapsulated with Brewer's Spent Yeast Mannoproteins-Study of Gastrointestinal and Colonic Bioaccessibility
Abstract
Calcium microcapsules were developed by spray-drying using mannoproteins (MPs) extracted from brewer's spent yeast, xanthan gum (XG), and maltodextrin as encapsulating materials. The formulas included 11 g of calcium, 24 g of MP, and 0, 2, 4, or 8 g of XG 100 g-1 solids, obtaining C1, C2, C3, and C4 microcapsules, respectively. Maltodextrin was added to complete 100 g of solids. Calcium intestinal (IB), colonic (CB), and total bioaccessibility (TB) were estimated after a simulated gastrointestinal digestion followed by in vitro colonic fermentation. The macromolecules of microcapsules interacted by ionic and hydrophobic forces. Microcapsules C1 and C2 showed a spherical shape. However, the addition of XG to the formulation contributed to the formation of concavities in the microcapsules. All microcapsules had higher IB than the control (CaCl2), probably due to the calcium-chelating peptides dialyzed from MP. Moreover, C1 and C2 showed the highest IB values (≈23%). However, C3 and C4 showed the highest CB values (≈11%), attributing this effect to the short-chain fatty acids produced during colonic fermentation. Finally, C1 and C2 showed the highest TB (31.8 ± 0.1 and 32.0 ± 0.4%, respectively). The use of MP allowed for obtaining a supplement with high calcium bioaccessibility.
Keywords: Saccharomyces cerevisiae; calcium dialyzability; glycoproteins; microcapsules; short-chain fatty acids; spray-drying.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Figures







Similar articles
-
From waste to worth: stability, bioaccessibility, and cellular antioxidant activity of microencapsulated red grape pomace phenolics.J Sci Food Agric. 2025 Jun 25. doi: 10.1002/jsfa.70010. Online ahead of print. J Sci Food Agric. 2025. PMID: 40557448
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Effects of yeast-enriched functionalized canola meal supplementation on apparent total tract macronutrient digestibility and fecal characteristics, fecal microbiota, and immune function of healthy adult dogs.J Anim Sci. 2024 Jan 3;102:skae224. doi: 10.1093/jas/skae224. J Anim Sci. 2024. PMID: 39101402 Free PMC article.
-
Treatments for seizures in catamenial (menstrual-related) epilepsy.Cochrane Database Syst Rev. 2021 Sep 16;9(9):CD013225. doi: 10.1002/14651858.CD013225.pub3. Cochrane Database Syst Rev. 2021. PMID: 34528245 Free PMC article.
-
Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.Cochrane Database Syst Rev. 2013 Apr 30;(4):CD008796. doi: 10.1002/14651858.CD008796.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2016 Mar 31;3:CD008796. doi: 10.1002/14651858.CD008796.pub3. PMID: 23633361 Updated.
References
-
- da Silva Araújo V.B., de Melo A.N.F., Costa A.G., Castro-Gomez R.H., Madruga M.S., de Souza E.L., Magnani M. Followed extraction of β-glucan and mannoprotein from spent brewer’s yeast (Saccharomyces uvarum) and application of the obtained mannoprotein as a stabilizer in mayonnaise. Innov. Food Sci. Emerg. Technol. 2014;23:164–170. doi: 10.1016/j.ifset.2013.12.013. - DOI
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous